IL104067A0 - Preparation of a pharmaceutical composition selectively lowering the blood-lipid level - Google Patents

Preparation of a pharmaceutical composition selectively lowering the blood-lipid level

Info

Publication number
IL104067A0
IL104067A0 IL104067A IL10406792A IL104067A0 IL 104067 A0 IL104067 A0 IL 104067A0 IL 104067 A IL104067 A IL 104067A IL 10406792 A IL10406792 A IL 10406792A IL 104067 A0 IL104067 A0 IL 104067A0
Authority
IL
Israel
Prior art keywords
blood
preparation
pharmaceutical composition
lipid level
composition selectively
Prior art date
Application number
IL104067A
Other languages
English (en)
Original Assignee
Mate Hidvegi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mate Hidvegi filed Critical Mate Hidvegi
Publication of IL104067A0 publication Critical patent/IL104067A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL104067A 1991-12-12 1992-12-11 Preparation of a pharmaceutical composition selectively lowering the blood-lipid level IL104067A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU913928A HU208256B (en) 1991-12-12 1991-12-12 Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood

Publications (1)

Publication Number Publication Date
IL104067A0 true IL104067A0 (en) 1993-05-13

Family

ID=10966105

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104067A IL104067A0 (en) 1991-12-12 1992-12-11 Preparation of a pharmaceutical composition selectively lowering the blood-lipid level

Country Status (25)

Country Link
US (1) US5277910A (fi)
JP (1) JPH05286865A (fi)
KR (1) KR930012033A (fi)
CN (1) CN1074123A (fi)
AT (1) ATA243992A (fi)
AU (1) AU657822B2 (fi)
BE (1) BE1006341A3 (fi)
CA (1) CA2085215A1 (fi)
CZ (1) CZ363492A3 (fi)
DE (1) DE4242149A1 (fi)
DK (1) DK148092A (fi)
ES (1) ES2055659B1 (fi)
FI (1) FI925633A (fi)
FR (1) FR2684877B1 (fi)
GB (1) GB2262230B (fi)
GR (1) GR920100548A (fi)
HU (1) HU208256B (fi)
IL (1) IL104067A0 (fi)
IT (1) IT1256652B (fi)
LU (1) LU88200A1 (fi)
MX (1) MX9207222A (fi)
NL (1) NL9202144A (fi)
PL (1) PL296972A1 (fi)
SE (1) SE9203744L (fi)
ZA (1) ZA929622B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208256B (en) * 1991-12-12 1993-09-28 Mate Hidvegi Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood
AU7250694A (en) * 1993-06-25 1995-01-17 Biosphere Technologies Inc. Dietary supplement incorporating beta-sitosterol and pectin
US5674496A (en) * 1993-10-20 1997-10-07 New Mexico Tech Research Foundation Animal repellent
US6814962B1 (en) * 1994-06-02 2004-11-09 Aventis Pharma S.A. Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
US5516528A (en) * 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
US6193766B1 (en) * 1996-06-27 2001-02-27 Barto/Jordan Company, Inc. Alfalfa extract fuel additive for reducing pollutant emissions
US6086882A (en) * 1997-08-06 2000-07-11 National Institute For Pharmaceutical Research Phytodrug for management of peptic ulcer and methods of preparing and using same
US5786343A (en) * 1997-03-05 1998-07-28 Immudyne, Inc. Phagocytosis activator compositions and their use
GB2327607B8 (en) * 1997-07-31 2005-03-30 Litton Internat Company Ltd A process for producing a herbal extract composition
DE19750453A1 (de) * 1997-11-14 1999-05-27 Henkel Kgaa Verwendung von Wirkstoffmischungen zur Herstellung von hypocholesterinämischen Mitteln
US6232351B1 (en) 1998-05-22 2001-05-15 Amway Corporation Co-processed botanical plant composition
US6150399A (en) * 1998-06-30 2000-11-21 Abbott Laboratories Soy-based nutritional products
DE19857816C2 (de) 1998-12-15 2001-02-01 Bionorica Arzneimittel Gmbh Fließfähige, pressfertige Arzneimittelvorprodukte für Tabletten, Pellets und Dragees, sowie Verfahren zu deren Herstellung
FR2794616B1 (fr) * 1999-06-11 2001-09-07 Tekory S A R L Supplement alimentaire naturel destine a diminuer le taux de cholesterol plasmatique et procede pour le preparer
US6503543B1 (en) * 2000-05-26 2003-01-07 Craig J. Hudson Tryptophan source from plants and uses therefor
US6866874B2 (en) 2000-05-26 2005-03-15 Susan P. Hudson Tryptophan source from plants and uses therefor
WO2002047612A2 (en) * 2000-10-27 2002-06-20 Mannatech, Inc. Dietary supplement compositions
US7815946B1 (en) * 2001-04-05 2010-10-19 Diakron Pharmaceuticals, Inc. Anti-diabetic and cholesterol lowering preparation from fenugreek seeds
JP5110673B2 (ja) * 2001-07-10 2012-12-26 丸善製薬株式会社 リパーゼ阻害剤
FR2854769B1 (fr) * 2003-05-16 2009-07-17 Alfalis Utilisation d'un extrait soluble de luzerne pour freiner la prise de poids chez les mammiferes
US20090318377A1 (en) * 2006-07-13 2009-12-24 Medicago Inc. Medicagenic acid saponin and uses thereof
US20090226549A1 (en) * 2008-03-06 2009-09-10 Kenneth John Hughes Herbal extracts and flavor systems for oral products and methods of making the same
CN103002871A (zh) * 2010-07-06 2013-03-27 荷兰联合利华有限公司 锦葵色素用来促进头发生长
KR20200040583A (ko) 2018-10-10 2020-04-20 (주)아모레퍼시픽 코티존 환원효소 저해용 조성물
CN114853918B (zh) * 2022-04-26 2023-03-31 沈阳化工大学 一种具有抗氧化降脂活性的紫花苜蓿根部多糖制备方法
CN115490584B (zh) * 2022-09-28 2023-07-14 厦门中药厂有限公司 Megastigmane类化合物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1136626A (en) * 1965-10-22 1968-12-11 Nat Res Dev Improvements relating to the extraction of saponins and sapogenins from vegetable materials
US3780183A (en) * 1971-01-25 1973-12-18 Edwards G Wheeler Plant protein product and process
US3901875A (en) * 1972-03-31 1975-08-26 Pacific Chem Ind Co Extraction of ginseng saponin
GB1378278A (en) * 1972-03-31 1974-12-27 Pacific Chem Ind Co Total saponin extracts from panax ginseng c a meyer and process for the production thereof
FR2187328A1 (en) * 1972-06-13 1974-01-18 Froment Pier E De Non-saponified lucerne extract - useful in dermatology cosmetology and as aid to cicatrisation
SU624634A1 (ru) * 1975-09-25 1978-09-25 Харьковский Научно-Исследовательский Химико-Фармацевтический Институт Способ получени ингибитора,обладающего антифибринолитическим и противовоспалительным действием
JPS59166055A (ja) * 1983-03-11 1984-09-19 Osaka Chem Lab 牧草を原料とする食品
JPS59175496A (ja) * 1983-03-23 1984-10-04 Osaka Chem Lab ソ−ヤサポニンの単離法
JPS646987A (en) * 1987-06-30 1989-01-11 Ricoh Kk Controlling method for toner concentration of developer for electrophotographic device
FR2669225B1 (fr) * 1990-11-21 1993-11-12 Lvmh Recherche Gie Utilisation de saponines de medicago pour la preparation de compositions cosmetiques ou pharmaceutiques, notamment dermatologiques.
HU208256B (en) * 1991-12-12 1993-09-28 Mate Hidvegi Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood

Also Published As

Publication number Publication date
FR2684877B1 (fr) 1994-12-30
DK148092A (da) 1993-06-13
PL296972A1 (en) 1993-08-23
LU88200A1 (fr) 1993-04-15
BE1006341A3 (fr) 1994-07-26
CZ363492A3 (en) 1993-09-15
GB2262230B (en) 1995-10-11
KR930012033A (ko) 1993-07-20
AU657822B2 (en) 1995-03-23
FR2684877A1 (fr) 1993-06-18
FI925633A0 (fi) 1992-12-11
NL9202144A (nl) 1993-07-01
DE4242149A1 (fi) 1993-06-17
ES2055659A1 (es) 1994-08-16
DK148092D0 (da) 1992-12-09
GR920100548A (el) 1993-08-31
HU913928D0 (en) 1992-02-28
AU3005492A (en) 1993-06-17
JPH05286865A (ja) 1993-11-02
GB9225866D0 (en) 1993-02-03
IT1256652B (it) 1995-12-12
CA2085215A1 (en) 1993-06-13
CN1074123A (zh) 1993-07-14
GB2262230A (en) 1993-06-16
SE9203744L (sv) 1993-06-13
ZA929622B (en) 1995-09-26
FI925633A (fi) 1993-06-13
MX9207222A (es) 1993-06-01
HU208256B (en) 1993-09-28
ITMI922842A0 (it) 1992-12-11
ES2055659B1 (es) 1995-03-01
ITMI922842A1 (it) 1994-06-11
SE9203744D0 (sv) 1992-12-11
US5277910A (en) 1994-01-11
ATA243992A (de) 2000-02-15

Similar Documents

Publication Publication Date Title
IL104067A0 (en) Preparation of a pharmaceutical composition selectively lowering the blood-lipid level
GB9213393D0 (en) Pharmaceutical composition
ZA923765B (en) Pharmaceutical composition
OA09535A (en) Pharmaceutical composition
GB9108080D0 (en) Pharmaceutical composition
GB2269382B (en) Pharmaceutical compounds
IL102435A0 (en) Pharmaceutical composition
GB2252497B (en) Pharmaceutical composition
GB9111477D0 (en) Pharmaceutical composition
ZA921848B (en) Pharmaceutical composition
GB9018039D0 (en) A pharmaceutical composition
ZA916592B (en) A pharmaceutical composition
GB9109975D0 (en) Medicinal compounds
GB9108129D0 (en) Pharmaceutical composition
GB9114149D0 (en) Pharmaceutical composition
GB9123491D0 (en) Pharmaceutical composition
GB9125862D0 (en) Pharmaceutical composition
GB9126612D0 (en) Pharmaceutical composition
GB9121138D0 (en) Pharmaceutical composition
GB9118343D0 (en) Pharmaceutical composition
GB9117360D0 (en) Pharmaceutical composition
GB9500393D0 (en) Pharmaceutical composition
HU9401681D0 (en) Pharmaceutical composition
ZA923671B (en) Pharmaceutical composition
ZA923077B (en) Pharmaceutical composition